Delivery Order SPE2DB24D2003-SPE2DB24FXGD0
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $16,866.69 firm-fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of REXULTI 2 MG TABLET 30S. The order has a period of performance through September 5, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of pharmaceutical products and medical...
This is a $2,820.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the antipsychotic medication REXULTI 1 MG TABLET 30S. The order has a performance period ending on June 24, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This $5,627.36 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The award is for the supply of REXULTI 3 MG TABLET 30S, a brand name pharmaceutical product, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $10,495.88 award is for the supply of 4564153098 - REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,249,991 units of the pharmaceutical product REXULTI 2 MG TABLET 30S. The $16,052.19 delivery order has a completion date of January 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, regularly provides pharmaceutical products and medical supplies to support DLA programs from its...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product REXULTI 0.5 MG TABLET 30S, with a ceiling value of $3,602.00 and a completion date of August 14, 2024. The contract is a Firm Fixed Price (FFP) Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
The U.S. Defense Logistics Agency (DLA) awarded a $1,914.33 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a completion date of January 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, provides a range of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This...
This is a $4,954.98 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical product REXULTI 2 MG TABLET 30S. The award has an ultimate completion date of November 6, 2024. Amerisourcebergen is a for-profit pharmaceutical distribution and healthcare solutions provider that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product REXULTI 0.5 MG TABLET 30S. The order has a completion date of March 8, 2024 and a potential value of $4,592.77. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
This is a $5,279.85 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product REXULTI 2 MG TABLET 30S. The order has an ultimate completion date of April 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, is not a small business set-aside contract. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of...